112 related articles for article (PubMed ID: 541529)
1. [Chronic toxicities of adriamycin (ADR) and their possible prevention by coenzyme Q10 and verapamil in rabbits--especially ADR induced cardiomyopathy (author's transl)].
Dohmae N; Sawada H; Tashima M; Uchino H; Matsuyama E; Konishi T
Nihon Gan Chiryo Gakkai Shi; 1979 Oct; 14(6):1009-28. PubMed ID: 541529
[No Abstract] [Full Text] [Related]
2. [Chronic cardiotoxicity of adriamycin and the possible prevention by coenzyme Q10 in rabbits (author's transl)].
Sawada H; Tashima M; Donomae N; Eguchi T; Uehara N; Shirakawa S; Yamagishi M; Nakamura T; Uchino H; Konishi T; Okazaki H; Matsuyama E
Nihon Gan Chiryo Gakkai Shi; 1979 Apr; 14(2):143-51. PubMed ID: 448221
[No Abstract] [Full Text] [Related]
3. [Chronic cardiotoxicity of anthracycline derivatives and possible prevention by coenzyme Q10].
Tajima M
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1211-6. PubMed ID: 6471423
[TBL] [Abstract][Full Text] [Related]
4. [Myocardial disease caused by adriamycin. Experimental animal models and possible pharmacologic prevention].
Decorti G; Bartoli Klugmann F; Klugmann S
Minerva Med; 1982 May; 73(19):1275-82. PubMed ID: 7078806
[TBL] [Abstract][Full Text] [Related]
5. Cardiomyopathy and other chronic toxic effects induced in rabbits by doxorubicin and possible prevention by coenzyme Q10.
Domae N; Sawada H; Matsuyama E; Konishi T; Uchino H
Cancer Treat Rep; 1981; 65(1-2):79-91. PubMed ID: 7226168
[TBL] [Abstract][Full Text] [Related]
6. [Study on establishment of condition in host for reinforcement of cancer chemotherapy effects --prevention of side effect of adriamycin treatment by CoQ10 (author's transl)].
Horikiri H; Morita N; Nagai T; Yunoki K
Igaku Kenkyu; 1979 Sep; 49(3):310-3. PubMed ID: 547646
[No Abstract] [Full Text] [Related]
7. Verapamil in the prevention of adriamycin-induced cardiomyopathy.
Garbrecht M; Müllerleile U
Klin Wochenschr; 1986; 64 Suppl 7():132-4. PubMed ID: 3560773
[No Abstract] [Full Text] [Related]
8. [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)].
Yamaguchi H; Toyota S; Takahara O; Ichimaru M
Rinsho Ketsueki; 1978 Aug; 19(8):1041-50. PubMed ID: 713049
[No Abstract] [Full Text] [Related]
9. Abrogation of adriamycin-induced cardiotoxicity by selenium in rabbits.
Dimitrov NV; Hay MB; Siew S; Hudler DA; Charamella LJ; Ullrey DE
Am J Pathol; 1987 Feb; 126(2):376-83. PubMed ID: 3826299
[TBL] [Abstract][Full Text] [Related]
10. Effects of L-carnitine on adriamycin-induced cardiomyopathy in rabbit.
Paterna S; Furitano G; Scaffidi L; Barbarino C; Campisi D; Parisi G; Carreca I
Int J Tissue React; 1984; 6(1):91-5. PubMed ID: 6715123
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin (adriamycin) cardiomyopathy.
Saltiel E; McGuire W
West J Med; 1983 Sep; 139(3):332-41. PubMed ID: 6356608
[TBL] [Abstract][Full Text] [Related]
12. Effect of selenium-vitamin E on adriamycin-induced cardiomyopathy in rabbits.
Van Vleet JF; Greenwood L; Ferrans VJ; Rebar AH
Am J Vet Res; 1978 Jun; 39(6):997-1010. PubMed ID: 666098
[TBL] [Abstract][Full Text] [Related]
13. Possible prevention from the progression of cardiotoxicity in adriamycin-treated rabbits by coenzyme Q10.
Usui T; Ishikura H; Izumi Y; Konishi H; Dohmae N; Sawada H; Uchino H; Matsuda H; Konishi T
Toxicol Lett; 1982 Jun; 12(1):75-82. PubMed ID: 7112605
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
Conklin KA
Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925
[TBL] [Abstract][Full Text] [Related]
15. Failure of carnitine to prevent adriamycin cardiomyopathy.
Goldsmith MA; Suzuki Y; Ohnuma T; Holland JF
Cancer Treat Rep; 1979 Apr; 63(4):558-60. PubMed ID: 445512
[No Abstract] [Full Text] [Related]
16. [Congestive cardiomyopathy after doxorubicin (adriamycin)author's transl)].
Kaduk B; Seiler G
Dtsch Med Wochenschr; 1977 Dec; 102(49):1813-7. PubMed ID: 271071
[TBL] [Abstract][Full Text] [Related]
17. Effects of pyrrolidine dithiocarbamate on antioxidant enzymes in cardiomyopathy induced by adriamycin in rats.
Mingyan E; Hongli L; Shufeng L; Bo Y
Cardiology; 2008; 111(2):119-25. PubMed ID: 18376123
[TBL] [Abstract][Full Text] [Related]
18. [Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin].
Okuma K; Furuta I; Ota K
Gan To Kagaku Ryoho; 1984 Mar; 11(3):502-8. PubMed ID: 6703724
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin-induced cardiomyopathy. A rat model.
Czarnecki A; Hinek A; Sołtysiak-Pawluczuk D
Pol J Pharmacol Pharm; 1986; 38(2):171-7. PubMed ID: 3748888
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathologic features of chronic adriamycin toxicosis in rabbits.
Van Vleet JF; Ferrans VJ
Am J Vet Res; 1980 Sep; 41(9):1462-9. PubMed ID: 7447139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
